US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ciber

0.3100

+0.0000

Volume:- -

Turnover:- -

Market Cap:25.31M

PE:-0.15

High:0.3100

Open:0.3100

Low:0.3100

Close:0.3100

Loading ...

Overview Company News Filings

Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009

AUD/USD strong bullish CBR pattern suggests further move up

Day One Biopharmaceuticals Shares Jump As Pediatric Brain Cancer Candidate Shows Encouraging Responses

This Pediatric Cancer Company Makes It To Analyst's Conviction List

100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML)

Carbon Revolution Announces Merger With Twin Ridge Capital Acquisition Corp

Desktop Outsourcing Market 2028 Key Insights and Leading Players Atos DXC Technology IBM Capgemini CGI Group Dell Fujitsu TCS T-Systems Unisys Accenture HCL Technologies Infosys Limited Cognizant NTT Data Corporation Ciber CompuCom Syste

Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort

Carbon (ASX:CBR) posts 66% revenue rise in Q1, shares skyrocket

Sermonix Pharmaceuticals Shares Additional Findings From Its ELAINE 1 Clinical Study at the 4th Annual Congress of the International Society of Liquid Biopsy

Carbon Revolution Says FY Underlying Loss After Tax (Excluding Significant Items) A$43 Million

Press Release: Ascentage Pharma Announces 2022 Interim Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CBR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBR\",,,,,undefined,":{"symbol":"CBR","market":"US","secType":"STK","nameCN":"Ciber","latestPrice":0.31,"timestamp":1499101200000,"preClose":0.31,"halted":0,"volume":0,"delay":0,"floatShares":71806040,"shares":81646000,"eps":-2.1,"marketStatus":"Trading","change":0,"latestTime":"04-25 13:56:09 EDT","open":0.31,"high":0.31,"low":0.31,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.1,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745611200000},"marketStatusCode":2,"adr":0,"listingDate":763880400000,"exchange":"NYSE","adjPreClose":0.31,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBR\",,,,,undefined,":{"symbol":"CBR","floatShares":71806040,"roa":"--","roe":"--","lyrEps":0,"shares":81646000,"dividePrice":0,"high":0.31,"amplitude":0,"preClose":0.31,"low":0.31,"week52Low":0.22,"pbRate":"0.16","week52High":2.36,"institutionHeld":0.7701,"latestPrice":0.31,"eps":-2.1,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.1,"open":0.31,"prevYearClose":0.31},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2311161228","title":"Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009","url":"https://stock-news.laohu8.com/highlight/detail?id=2311161228","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2311161228?lang=en_us&edition=fundamental","pubTime":"2023-02-14 19:59","pubTimestamp":1676375940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bicycle-therapeutics-announces-phase-dose-115900318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ITT","CBR","BK4139","BCYC","BK4161"],"gpt_icon":0},{"id":"2304984131","title":"AUD/USD strong bullish CBR pattern suggests further move up","url":"https://stock-news.laohu8.com/highlight/detail?id=2304984131","media":"FXStreet","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2304984131?lang=en_us&edition=fundamental","pubTime":"2023-01-20 16:50","pubTimestamp":1674204617,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"redbox_crawler","url":"https://news.google.com/__i/rss/rd/articles/CBMiamh0dHBzOi8vd3d3LmZ4c3RyZWV0LmNvbS9hbmFseXNpcy9hdWQtdXNkLXN0cm9uZy1idWxsaXNoLWNici1wYXR0ZXJuLXN1Z2dlc3RzLWZ1cnRoZXItbW92ZS11cC0yMDIzMDEyMDA3NTDSAW5odHRwczovL3d3dy5meHN0cmVldC5jb20vYW1wL2FuYWx5c2lzL2F1ZC11c2Qtc3Ryb25nLWJ1bGxpc2gtY2JyLXBhdHRlcm4tc3VnZ2VzdHMtZnVydGhlci1tb3ZlLXVwLTIwMjMwMTIwMDc1MA?oc=5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://news.google.com/__i/rss/rd/articles/CBMiamh0dHBzOi8vd3d3LmZ4c3RyZWV0LmNvbS9hbmFseXNpcy9hdWQtdXNkLXN0cm9uZy1idWxsaXNoLWNici1wYXR0ZXJuLXN1Z2dlc3RzLWZ1cnRoZXItbW92ZS11cC0yMDIzMDEyMDA3NTDSAW5odHRwczovL3d3dy5meHN0cmVldC5jb20vYW1wL2FuYWx5c2lzL2F1ZC11c2Qtc3Ryb25nLWJ1bGxpc2gtY2JyLXBhdHRlcm4tc3VnZ2VzdHMtZnVydGhlci1tb3ZlLXVwLTIwMjMwMTIwMDc1MA?oc=5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"redbox_crawler","symbols":["USD","BK4125","AUD","CBR"],"gpt_icon":0},{"id":"2302706030","title":"Day One Biopharmaceuticals Shares Jump As Pediatric Brain Cancer Candidate Shows Encouraging Responses","url":"https://stock-news.laohu8.com/highlight/detail?id=2302706030","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2302706030?lang=en_us&edition=fundamental","pubTime":"2023-01-09 21:57","pubTimestamp":1673272632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WTmTGDELw75jyreFxpnNEg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/ce8478c6726fe97aeb0b481bf61ce127","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WTmTGDELw75jyreFxpnNEg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/ce8478c6726fe97aeb0b481bf61ce127"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/day-one-biopharmaceuticals-shares-jump-135712085.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4139","DAWN","CBR"],"gpt_icon":0},{"id":"2291089135","title":"This Pediatric Cancer Company Makes It To Analyst's Conviction List","url":"https://stock-news.laohu8.com/highlight/detail?id=2291089135","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2291089135?lang=en_us&edition=fundamental","pubTime":"2022-12-15 02:02","pubTimestamp":1671040979,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/V_hYPKAw0Om3S9KHO4cr4g--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/1180fb8e721563600584531e2605369d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/V_hYPKAw0Om3S9KHO4cr4g--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/1180fb8e721563600584531e2605369d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pediatric-cancer-company-makes-analysts-180259639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","DAWN","BK4139","CBR"],"gpt_icon":0},{"id":"2290781969","title":"100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML)","url":"https://stock-news.laohu8.com/highlight/detail?id=2290781969","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2290781969?lang=en_us&edition=fundamental","pubTime":"2022-12-12 20:35","pubTimestamp":1670848500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX4lFghIfeHvaf3GE2OfYQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/5c87d755d6d224cdf4b775531ab18087","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX4lFghIfeHvaf3GE2OfYQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/5c87d755d6d224cdf4b775531ab18087"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/100-clinical-benefit-rate-achieved-123500248.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CBR","BK4139","APVO","ASH","CRS","BK4109","BK4006"],"gpt_icon":0},{"id":"2287352626","title":"Carbon Revolution Announces Merger With Twin Ridge Capital Acquisition Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2287352626","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2287352626?lang=en_us&edition=fundamental","pubTime":"2022-11-30 09:29","pubTimestamp":1669771746,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBR","TRCA.U"],"gpt_icon":0},{"id":"2287250375","title":"Desktop Outsourcing Market 2028 Key Insights and Leading Players Atos DXC Technology IBM Capgemini CGI Group Dell Fujitsu TCS T-Systems Unisys Accenture HCL Technologies Infosys Limited Cognizant NTT Data Corporation Ciber CompuCom Syste","url":"https://stock-news.laohu8.com/highlight/detail?id=2287250375","media":"Skegness Siren","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2287250375?lang=en_us&edition=fundamental","pubTime":"2022-11-29 14:02","pubTimestamp":1669701734,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"redbox_crawler","url":"https://news.google.com/__i/rss/rd/articles/CBMi8wFodHRwczovL3d3dy5za2VnbmVzc3NpcmVuLmNvLnVrLzIwMjIvMTEvMjgvZGVza3RvcC1vdXRzb3VyY2luZy1tYXJrZXQtMjAyOC1rZXktaW5zaWdodHMtYW5kLWxlYWRpbmctcGxheWVycy1hdG9zLWR4Yy10ZWNobm9sb2d5LWlibS1jYXBnZW1pbmktY2dpLWdyb3VwLWRlbGwtZnVqaXRzdS10Y3MtdC1zeXN0ZW1zLXVuaXN5cy1hY2NlbnR1cmUtaGNsLXRlY2hub2xvZ2llcy1pbmZvc3lzLWxpbWl0ZWQtY29nbml6YW50LW50dC_SAQA?oc=5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://news.google.com/__i/rss/rd/articles/CBMi8wFodHRwczovL3d3dy5za2VnbmVzc3NpcmVuLmNvLnVrLzIwMjIvMTEvMjgvZGVza3RvcC1vdXRzb3VyY2luZy1tYXJrZXQtMjAyOC1rZXktaW5zaWdodHMtYW5kLWxlYWRpbmctcGxheWVycy1hdG9zLWR4Yy10ZWNobm9sb2d5LWlibS1jYXBnZW1pbmktY2dpLWdyb3VwLWRlbGwtZnVqaXRzdS10Y3MtdC1zeXN0ZW1zLXVuaXN5cy1hY2NlbnR1cmUtaGNsLXRlY2hub2xvZ2llcy1pbmZvc3lzLWxpbWl0ZWQtY29nbml6YW50LW50dC_SAQA?oc=5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"redbox_crawler","symbols":["BK4515","LU0321505439.SGD","BK4134","BK4579","LU0323240290.USD","LU1303367103.USD","IBM","LU1032466523.USD","LU1366334578.USD","LU1366334651.USD","LU2098885051.SGD","LBIX","DVMT","ACN","BK4505","BK4200","LU2087621335.USD","BK4566","BK4534","LU0321505868.SGD","BK4575","DELL","BK4523","CGI","BK4170","DXC","UIS","CTSH","BK4504","BK4538","LU1839511570.USD","NTT","IE00B3M56506.USD","BK4581","BK4585","LU0006061336.USD","BK4533","BK4526","BK4139","TCS","NTTDF","LU0333810181.USD","CBR","LU0791590937.USD","BK4535","BK4548","LU0791591158.USD","INFY","BGNE","BK4561"],"gpt_icon":0},{"id":"2282619290","title":"Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2282619290","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2282619290?lang=en_us&edition=fundamental","pubTime":"2022-11-10 22:01","pubTimestamp":1668088860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/V4HsdfDOffpXrk.cqSWj5Q--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6f3fee9112cd498f5706afb24313777e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/V4HsdfDOffpXrk.cqSWj5Q--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6f3fee9112cd498f5706afb24313777e"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/oncolytics-biotech-presents-updated-clinical-140100887.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-presents-updated-clinical-140100887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KOL","BK4080","SD","CRCT","PDAC","BK4539","SITC","BK4213","ONCY","CBR","PR","CR","LINK","AIO","BK4139","BK4007","BK4191","TERN","BK4161"],"gpt_icon":0},{"id":"2279387311","title":"Carbon (ASX:CBR) posts 66% revenue rise in Q1, shares skyrocket","url":"https://stock-news.laohu8.com/highlight/detail?id=2279387311","media":"Kalkine Media","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2279387311?lang=en_us&edition=fundamental","pubTime":"2022-10-31 10:02","pubTimestamp":1667181720,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://kalkinemedia.com/resources/assets/placeholders/350x250.jpg","type":0,"news_type":0,"thumbnails":["https://kalkinemedia.com/resources/assets/placeholders/350x250.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://kalkinemedia.com/au/stocks/consumer/carbon-reports-66-revenue-surge-in-q1-shares-skyrocket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kalkinemedia_stock","symbols":["ASX.AU","XJO.AU","CBR","ASX","XAO.AU","XKO.AU","CBR.AU"],"gpt_icon":0},{"id":"2277408848","title":"Sermonix Pharmaceuticals Shares Additional Findings From Its ELAINE 1 Clinical Study at the 4th Annual Congress of the International Society of Liquid Biopsy","url":"https://stock-news.laohu8.com/highlight/detail?id=2277408848","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2277408848?lang=en_us&edition=fundamental","pubTime":"2022-10-21 22:00","pubTimestamp":1666360800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tsOojrKOs74QbcOF7xdIEQ--~B/aD0zMDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/l6bR8fDOV_OoYZ1Mckd1.g--~B/aD0zMDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93f5dcf5fc18960535fc9f787f05d237","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tsOojrKOs74QbcOF7xdIEQ--~B/aD0zMDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/l6bR8fDOV_OoYZ1Mckd1.g--~B/aD0zMDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93f5dcf5fc18960535fc9f787f05d237"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sermonix-pharmaceuticals-shares-additional-findings-140000024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LGND","PFS","BK4191","BK4007","BK4539","BK4195","TERN","CRCT","CBR"],"gpt_icon":0},{"id":"2263112119","title":"Carbon Revolution Says FY Underlying Loss After Tax (Excluding Significant Items) A$43 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2263112119","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2263112119?lang=en_us&edition=fundamental","pubTime":"2022-08-29 06:30","pubTimestamp":1661725832,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBR"],"gpt_icon":0},{"id":"2262971842","title":"Press Release: Ascentage Pharma Announces 2022 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2262971842","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2262971842?lang=en_us&edition=fundamental","pubTime":"2022-08-27 00:47","pubTimestamp":1661532420,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4515","BK4527","BK1574","CHB","BK4550","CDE","NPP","CSCO","BK4560","BK4017","BK1161","BK4534","BK4525","BK4579","BK4020","BK4097","CACA","BK4533","06855","TLS","CBR"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-08","symbol":"CBR","fiscalQuarterEnding":null,"expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1478581200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-08-04","symbol":"CBR","fiscalQuarterEnding":null,"expectedEps":-0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1470283200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-05","symbol":"CBR","fiscalQuarterEnding":null,"expectedEps":-0.13,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1462420800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-02-18","symbol":"CBR","fiscalQuarterEnding":null,"expectedEps":0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1455771600000,"reportTimeType":"pre","actualEps":0.01},{"market":"US","date":"2015-10-29","symbol":"CBR","fiscalQuarterEnding":null,"expectedEps":0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1446091200000,"reportTimeType":"pre","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBR\",market:\"US\",delay:false,,,undefined,":{}}}